CCN2 and metabolic dysfunction-associated steatohepatitis: A 2.7-fold increase in CCN2 expression was documented by microarray analysis of hepatocytes isolated from 35-week Pten knock-out mice, which develop NASH-like liver pathology leading the authors to speculate that CCN2 was involved in NASH fibrosis or cancer [64].